# Ginger Osteoarthritis Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/ginger-osteoarthritis-randomized-trial-evidence-review
Category: evidence-review
Summary: Ginger Osteoarthritis Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are 
Last reviewed: 2026-06-04
Reviewed by: Migaku Evidence Review
# Ginger Osteoarthritis Randomized Trial: What the Evidence Says

## Quick Answer

Ginger Osteoarthritis Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 narrative review, 1 research article.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Ginger Bioactives as Multi-Target Therapeutics: Mechanisms, Delivery Innovation, and Human Health Impact | narrative review | 3 | 2026-03-27 | 10.3390/nu18071079 |
| Spices Beyond Antioxidants: From the Gut to the Brain. | research article | 4 | 2026-06-01 | 10.1093/nutrit/nuaf176 |

## What The Sources Report

- Zingiber officinale 1 2 3 4 5 Ginger (Roscoe) is a perennial herb belonging to the Zingiberaceae family and is predominantly found in Southeast Asia. [Simeone Pasquale (2026); evidence level 3]
- The precise geographic origin of ginger remains uncertain; however, historical evidence suggests that it was first cultivated in China and neighboring regions of Southeast Asia. [Simeone Pasquale (2026); evidence level 3]
- Objectives The objective of this review was to summarize evidence of the effects of select spices/herbs on human health with a focus on the work conducted at the University of California-Los Angeles (UCLA) Center for Human Nutrition. [Diacova T (2026); evidence level 4]
- (Poly)phenols are not accessible by the human digestive enzymes and are metabolized by the gut microbiome, earning them the status of "prebiotics." This is confirmed by a vast body of evidence pointing to the herbs'/spices' ability to affect gut microbiota composition/functionality. [Diacova T (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

For ginger osteoarthritis randomized trial, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Simeone Pasquale (2026). Ginger Bioactives as Multi-Target Therapeutics: Mechanisms, Delivery Innovation, and Human Health Impact. DOI: 10.3390/nu18071079. PMCID: PMC13074413. PMID: 41978129. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13074413/
- Diacova T (2026). Spices Beyond Antioxidants: From the Gut to the Brain.. DOI: 10.1093/nutrit/nuaf176. PMCID: PMC13201883. PMID: 42186275. https://pmc.ncbi.nlm.nih.gov/articles/PMC13201883/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.